South Asian Heart Health Awareness and Research Act of 2017

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply.

Client expense: $380,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.Res479- A resolution designating April 2018 as "National Donate Life Month"

Client expense: $102,265 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention, including the Bipartisan Budget Act of 2018, HR 1892, and HR 1625, the Consolidated Appropriations Act of 2018; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.

Client expense: $490,000 · Firm income: Not reported

American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Graham Cassidy H.Res.752-Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as the global public health crisis of our generation and recognizing February 2018 as "American Heart Month" H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951) S.Res.403-A resolution designating February 2018 as "American Heart Month" and February 2, 2018, as "National Wear Red Day" Tax Cuts and Jobs Act(H.R.1)(P.L.115-97)

Client expense: $45,380 · Firm income: Not reported

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA User Fee Program reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309/S 920, the National Diabetes Clinical Care Commission Act; reduction of administrative burdens; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.

Client expense: $440,000 · Firm income: Not reported